For centuries, MS was recognized as a condition characterized by episodic and progressive neurological deterioration, classified as ‘paraplegia’
It is difficult to diagnose Parkinson’s disease, and the only way to confirm diagnosis is postmortem. The new imaging AI tools could be the answer.
The neuro tech has speed up in the recent years and staying on top of trends is becoming a must in the neuro research. Choosing the right tech when...
Boston, MA, 29/11/21 QMENTA announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its QMENTA Platform for...
The importance of Data Protection and Data Integrity in Imaging Clinical Trials
Diffusion MRI (dMRI) is a vital imaging technique that provides great insight into the brain microstructure. These microstructural properties of the...
There has been a massive acceleration of digitally driven innovation in our lives as of late and the life sciences industry is of course no exception.
There has been a massive acceleration of digitally driven innovation in our lives as of late and the life sciences industry is of course no exception.
There is a huge unmet need in treating patients with brain diseases; clinical trials fail and finding effective therapies is hard.